in 1962, following the examination of samples collected from individuals who had manifested symptoms of respiratory tract infection (Hamre & Procknow, 1966). Initially, CoVs were not considered as highly pathogenic for humans. That was until 2002, however, that CoVs emerged in the form of Severe Acute Respiratory Syndrome (SARS) in the Guangdong state of China (Sahin et al., 2020). Almost a decade later, another highly pathogenic CoV appeared in the Middle East countries, which similarly led to severe respiratory symptoms of acute onset. The then‐novel species was named Middle East Respiratory Syndrome Coronavirus (MERS‐CoV; Zaki, Van Boheemen, Bestebroer, Osterhaus, & Fouchier, 2012).
In December 2019, a cluster of insidious Coronavirus infections was reported in t